These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17892441)

  • 1. Redefining functional sensitivity of thyroglobulin assay on Immulite platform: implications in thyroid cancer management.
    Giovanella L; Ceriani L; Ghelfo A
    Clin Chem Lab Med; 2007; 45(11):1523-4. PubMed ID: 17892441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.
    Giovanella L; Ceriani L
    Clin Chem Lab Med; 2002 May; 40(5):480-4. PubMed ID: 12113292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the first automated thyroglobulin assay.
    Vogeser M; Knesewitsch P; Jacob K; Seidel D
    Clin Chem Lab Med; 1999 Feb; 37(2):159-64. PubMed ID: 10219505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
    Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
    Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin.
    Wunderlich G; Zöphel K; Crook L; Smith S; Smith BR; Franke WG
    Thyroid; 2001 Sep; 11(9):819-24. PubMed ID: 11575850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
    Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.
    Ferrari L; Seregni E; Aliberti G; Martinetti A; Pallotti F; Villano C; Lucignani G; Bombardieri E
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):237-42. PubMed ID: 15499298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.
    Giovanella L; Ceriani L; Ghelfo A; Keller F; Sacchi A; Maffioli M; Spriano G
    Clin Chem Lab Med; 2006; 44(5):648-52. PubMed ID: 16681439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.
    Elisei R; Vivaldi A; Agate L; Molinaro E; Nencetti C; Grasso L; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):33-9. PubMed ID: 14715824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma].
    Sahlmann CO; Schreivogel I; Angerstein C; Siefker U; Lehmann K; Altenvoerde G; Hüfner M; Meller J
    Nuklearmedizin; 2003; 42(2):71-7. PubMed ID: 12695789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.
    Cho YY; Chun S; Lee SY; Chung JH; Park HD; Kim SW
    Ann Lab Med; 2016 Sep; 36(5):413-9. PubMed ID: 27374705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer.
    Spencer C; Fatemi S; Singer P; Nicoloff J; Lopresti J
    Thyroid; 2010 Jun; 20(6):587-95. PubMed ID: 20470203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two thyroglobulin immunoradiometric assays on the basis of comprehensive imaging in differentiated thyroid carcinoma.
    Mikosch P; Gallowitsch HJ; Kresnik E; Unterweger O; Gomez I; Lind P
    Thyroid; 1999 Sep; 9(9):933-41. PubMed ID: 10524573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.
    Schlumberger M; Fragu P; Gardet P; Lumbroso J; Violot D; Parmentier C
    Eur J Nucl Med; 1991; 18(3):153-7. PubMed ID: 2040337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of a new IRMA for determining thyroglobulin].
    Heinze HG; Rall M
    Nuklearmedizin; 1992 Oct; 31(5):172-7. PubMed ID: 1465354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457).
    Lee JI; Kim JY; Choi JY; Kim HK; Jang HW; Hur KY; Kim JH; Kim KW; Chung JH; Kim SW
    Head Neck; 2010 Sep; 32(9):1161-6. PubMed ID: 20029980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.